Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.67 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.50 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.50 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.50 |
| ▸ | HTR1A | P08908 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.50 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.50 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25408257 | 0.98 | ADRA2A (0.69) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL28047745 | 0.94 | ADRA2A (0.69) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL1984572 | 0.92 | ADRA2A (0.78) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL8087675 | 0.92 | ADRA2A (0.78) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL12560596 | 0.90 | ADRA2A (0.69) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Iodide SCHEMBL15378186 | 0.90 | ADRA2A (0.75) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Iodide SCHEMBL1980845 | 0.90 | ADRA2A (0.75) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL16353067 | 0.90 | ADRA2A (0.82) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Choline SCHEMBL25406334 | 0.87 | ADRA2A (0.60) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL3037579 | 0.86 | ADRA2A (0.83) | ADRA2AADRA1AMAPTBLMCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250186319-A1 | ANAPLEROTIC COMPOSITIONS AND USES THEREOF | EXCELLA BIOSCIENTIFIC LTD (IL) | 2025-06-12 | — | — | US | disclosed |
| CN-116059129-A | Skin moisturizer and preparation method thereof | 广东丸美生物技术股份有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-114028262-A | Preparation method and application of azelaic acid ionic salt/eutectic cyclodextrin inclusion compound liposome | 深圳市萱嘉生物科技有限公司 | 2022-02-11 | — | — | CN | disclosed |
| US-6120779-A | MOISTURIZING | SOMA TECHNOLOGIES (US) | 2000-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250186319-A1 | ANAPLEROTIC COMPOSITIONS AND USES THEREOF | OAT, PC, ACAT1 | ADRA2A 4116/4885ADRA1A 3975/4885MAPT 2101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.